{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039594","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.075844+00:00","generated_at":"2026-05-30T19:16:44.544432+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sigyn Therapeutics issues 118,700 shares on conversion of $474,793 in debentures at $4.00/share","bullets":["Holders of $474,793 in convertible debentures converted at $4.00/share; 118,700 restricted shares issued.","Outstanding common shares increased from 1,301,978 to 1,420,678 as a result.","Conversion exempt from registration under Section 4(a)(2); holders are executive-officer-controlled accredited investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039594","json":"https://secwatch.observer/filing/0001493152-24-039594.json","markdown":"https://secwatch.observer/filing/0001493152-24-039594.md","text":"https://secwatch.observer/filing/0001493152-24-039594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/0001493152-24-039594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:16:44.544432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}